InsiderTrades.com logo

RCUS Insider Trading

Insider Ownership Percentage: 12.30%
Insider Buying (Last 12 Months): $402,764.00
Insider Selling (Last 12 Months): $56,989.32

Arcus Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Arcus Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arcus Biosciences Share Price & Price History

Current Price: $8.30
Price Change: ▼ Price Decrease of -0.11 (-1.31%)
As of 04/25/2025 04:59 PM ET

This chart shows the closing price history over time for RCUS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Arcus Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/27/2025Terry J. RosenCEOBuy19,800$10.18$201,564.002,554,160View SEC Filing Icon  
2/27/2025Yasunori KanekoDirectorBuy20,000$10.06$201,200.0028,400View SEC Filing Icon  
12/31/2024Robert C Goeltz IICFOSell3,594$15.00$53,910.0060,138View SEC Filing Icon  
12/2/2024Alexander AzoyCAOSell201$15.32$3,079.3219,070View SEC Filing Icon  
3/27/2024Jennifer JarrettCOOSell11,551$17.55$202,720.05215,253View SEC Filing Icon  
3/18/2024Jennifer JarrettCOOSell13,449$17.92$241,006.08226,804View SEC Filing Icon  
2/26/2024Jennifer JarrettCOOSell24,555$20.07$492,818.85274,323View SEC Filing Icon  
2/26/2024Juan C. JaenPresidentSell3,900$20.06$78,234.001,211,365View SEC Filing Icon  
1/29/2024Gilead Sciences, Inc.Major ShareholderBuy15,238,095$21.00$319,999,995.0030,061,124View SEC Filing Icon  
1/2/2024Juan C. JaenPresidentSell6,975$20.09$140,127.751,215,265View SEC Filing Icon  
1/2/2024Robert C Goeltz IICFOSell2,004$20.00$40,080.0051,831View SEC Filing Icon  
12/22/2023Jennifer JarrettCOOSell21,521$17.76$382,212.96258,878View SEC Filing Icon  
9/22/2023Jennifer JarrettCOOSell21,369$19.99$427,166.31302,691View SEC Filing Icon  
7/28/2023Jennifer JarrettCOOSell45,000$20.25$911,250.00336,566View SEC Filing Icon  
7/3/2023Alexander AzoyCAOSell1,018$20.41$20,777.3811,596View SEC Filing Icon  
6/28/2023Gilead Sciences, Inc.Major ShareholderBuy1,010,000$19.26$19,452,600.0014,823,029View SEC Filing Icon  
6/22/2023Jennifer JarrettCOOSell12,437$19.12$237,795.44381,566View SEC Filing Icon  
6/16/2023Jennifer JarrettCOOSell12,563$19.35$243,094.05394,003View SEC Filing Icon  
3/16/2023Jennifer JarrettCOOSell8,729$16.81$146,734.49406,217View SEC Filing Icon  
1/26/2023Jennifer JarrettCOOSell300$23.56$7,068.00416,546View SEC Filing Icon  
12/16/2022Carolyn C TangGeneral CounselSell2,523$30.75$77,582.2528,584View SEC Filing Icon  
12/16/2022Jennifer JarrettCOOSell16,482$30.75$506,821.50147,609View SEC Filing Icon  
12/16/2022Juan C. JaenPresidentSell4,436$30.75$136,407.00218,258View SEC Filing Icon  
12/16/2022Robert C Goeltz IICFOSell2,453$30.75$75,429.7511,566View SEC Filing Icon  
12/16/2022Terry J. RosenCEOSell13,043$30.75$401,072.25242,173View SEC Filing Icon  
9/16/2022Jennifer JarrettCOOSell12,677$26.28$333,151.56130,942View SEC Filing Icon  
6/16/2022Carolyn C TangGeneral CounselSell1,400$20.72$29,008.0025,431View SEC Filing Icon  
6/16/2022Jennifer JarrettCOOSell6,081$20.72$125,998.32125,233View SEC Filing Icon  
6/16/2022Juan C. JaenPresidentSell2,333$20.72$48,339.76212,574View SEC Filing Icon  
6/16/2022Terry J. RosenCEOSell4,241$20.72$87,873.52232,329View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Arcus Biosciences (NYSE:RCUS)

92.89% of Arcus Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RCUS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Arcus Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/25/2025Amalgamated Bank18,797$0.15M0.0%+18.4%0.018%Search for SEC Filing on Google Icon
4/24/2025Allspring Global Investments Holdings LLC18,405$0.14M0.0%+54.0%0.018%Search for SEC Filing on Google Icon
4/21/2025State of Alaska Department of Revenue37,288$0.29M0.0%+21.9%0.035%Search for SEC Filing on Google Icon
4/17/2025Exchange Traded Concepts LLC13,922$0.11M0.0%+40.5%0.013%Search for SEC Filing on Google Icon
4/14/2025Yousif Capital Management LLC24,829$0.20M0.0%+18.6%0.024%Search for SEC Filing on Google Icon
4/8/2025Rhumbline Advisers182,909$1.44M0.0%+14.8%0.174%Search for SEC Filing on Google Icon
4/7/2025GAMMA Investing LLC16,571$1.30M0.0%+1,399.6%0.016%Search for SEC Filing on Google Icon
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC62,014$0.92M0.0%-11.3%0.068%Search for SEC Filing on Google Icon
2/17/2025Woodline Partners LP3,523,937$52.47M0.4%+1.3%3.851%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP58,800$0.88M0.0%+35.8%0.064%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP146,686$2.18M0.0%+8.1%0.160%Search for SEC Filing on Google Icon
2/17/2025Teza Capital Management LLC10,198$0.15M0.0%-25.5%0.011%Search for SEC Filing on Google Icon
2/17/2025Tema Etfs LLC22,233$0.33M0.1%N/A0.024%Search for SEC Filing on Google Icon
2/17/2025Suvretta Capital Management LLC576,156$8.58M0.3%-13.2%0.630%Search for SEC Filing on Google Icon
2/17/2025Rafferty Asset Management LLC77,682$1.16M0.0%-7.7%0.085%Search for SEC Filing on Google Icon
2/17/2025Point72 Asia Singapore Pte. Ltd.15,183$0.23M0.1%-25.4%0.017%Search for SEC Filing on Google Icon
2/17/2025Point72 Asset Management L.P.1,996,279$29.73M0.1%-18.1%2.181%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC16,379$0.24M0.0%+44.4%0.018%Search for SEC Filing on Google Icon
2/17/2025Parkman Healthcare Partners LLC1,273,789$18.97M2.5%+24.2%1.392%Search for SEC Filing on Google Icon
2/17/2025Man Group plc12,578$0.19M0.0%-65.0%0.014%Search for SEC Filing on Google Icon
2/17/2025Nuveen Asset Management LLC131,859$1.96M0.0%-22.4%0.144%Search for SEC Filing on Google Icon
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 76,646$1.14M0.1%+140.6%0.084%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC924,369$13.76M0.0%+277.1%1.010%Search for SEC Filing on Google Icon
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.34,007$0.51M0.0%+2.5%0.037%Search for SEC Filing on Google Icon
2/17/2025Lazard Asset Management LLC6,261$93K0.0%+3,321.3%0.007%Search for SEC Filing on Google Icon
2/17/2025Jacobs Levy Equity Management Inc.465,304$6.93M0.0%N/A0.508%Search for SEC Filing on Google Icon
2/17/2025Hudson Bay Capital Management LP170,000$2.53M0.0%-2.9%0.186%Search for SEC Filing on Google Icon
2/17/2025Granahan Investment Management LLC346,093$5.15M0.2%-3.3%0.378%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG50,218$0.75M0.0%+46.7%0.055%Search for SEC Filing on Google Icon
2/17/2025DAFNA Capital Management LLC254,217$3.79M1.0%-1.0%0.278%Search for SEC Filing on Google Icon
2/17/2025Cubist Systematic Strategies LLC225,167$3.35M0.0%+220.3%0.246%Search for SEC Filing on Google Icon
2/17/2025Braidwell LP802,100$11.94M0.4%N/A0.877%Search for SEC Filing on Google Icon
2/17/2025Brevan Howard Capital Management LP14,279$0.21M0.0%+38.3%0.016%Search for SEC Filing on Google Icon
2/17/2025Balyasny Asset Management L.P.58,194$0.87M0.0%+19.8%0.064%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE160,145$2.39M0.0%+13.6%0.175%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets20,341$0.30M0.0%+79.6%0.022%Search for SEC Filing on Google Icon
2/17/2025Ameriprise Financial Inc.1,547,591$23.04M0.0%+17.3%1.691%Search for SEC Filing on Google Icon
2/17/2025Algert Global LLC180,122$2.68M0.1%+59.6%0.197%Search for SEC Filing on Google Icon
2/14/2025Boxer Capital Management LLC1,602,200$23.86M2.0%N/A1.751%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC202,500$3.02M0.0%-6.7%0.221%Search for SEC Filing on Google Icon
2/14/2025PDT Partners LLC125,752$1.87M0.2%+43.5%0.137%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC134,997$2.01M0.0%-80.0%0.148%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp532,099$7.92M0.0%+4.3%0.581%Search for SEC Filing on Google Icon
2/14/2025Tudor Investment Corp ET AL42,968$0.64M0.0%-5.9%0.047%Search for SEC Filing on Google Icon
2/14/2025Decheng Capital LLC808,789$12.04M2.6%-7.0%0.884%Search for SEC Filing on Google Icon
2/14/2025Virtus ETF Advisers LLC4,143$62K0.0%-23.6%0.005%Search for SEC Filing on Google Icon
2/14/2025Gilder Gagnon Howe & Co. LLC119,050$1.77M0.0%-5.8%0.130%Search for SEC Filing on Google Icon
2/14/2025Voya Investment Management LLC24,674$0.37M0.0%+37.5%0.027%Search for SEC Filing on Google Icon
2/14/2025Adage Capital Partners GP L.L.C.443,000$6.60M0.0%N/A0.484%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD30,948$0.46M0.0%-16.8%0.034%Search for SEC Filing on Google Icon
2/14/2025Dark Forest Capital Management LP30,202$0.45M0.1%+102.8%0.033%Search for SEC Filing on Google Icon
2/14/2025Diadema Partners LP165,965$2.47M1.0%N/A0.181%Search for SEC Filing on Google Icon
2/14/2025MetLife Investment Management LLC33,525$0.50M0.0%+8.1%0.037%Search for SEC Filing on Google Icon
2/14/2025Dimensional Fund Advisors LP1,702,302$25.35M0.0%+11.7%1.860%Search for SEC Filing on Google Icon
2/14/2025First Trust Advisors LP17,708$0.26M0.0%+43.1%0.019%Search for SEC Filing on Google Icon
2/14/2025Gilead Sciences Inc.30,061,124$447.61M28.9%N/A32.850%Search for SEC Filing on Google Icon
2/13/2025PEAK6 LLC10,000$0.15M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/13/2025Jump Financial LLC17,244$0.26M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd18,434$0.27M0.0%+64.7%0.020%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC113,038$1.68M0.0%-4.8%0.124%Search for SEC Filing on Google Icon
2/13/2025Raymond James Financial Inc.35,662$0.53M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC18,500$0.28M0.0%-89.9%0.020%Search for SEC Filing on Google Icon
2/13/2025Legal & General Group Plc149,207$2.22M0.0%-1.2%0.163%Search for SEC Filing on Google Icon
2/13/2025Invesco Ltd.203,987$3.04M0.0%+21.4%0.223%Search for SEC Filing on Google Icon
2/13/2025Russell Investments Group Ltd.29,953$0.45M0.0%+187.7%0.033%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN38,618$0.58M0.0%+105.9%0.042%Search for SEC Filing on Google Icon
2/12/2025ExodusPoint Capital Management LP60,193$0.90M0.0%N/A0.066%Search for SEC Filing on Google Icon
2/12/2025Massachusetts Financial Services Co. MA78,544$1.17M0.0%-2.9%0.086%Search for SEC Filing on Google Icon
2/12/2025Trexquant Investment LP300,548$4.48M0.1%+241.5%0.328%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC1,209,613$18.02M0.0%-1.0%1.322%Search for SEC Filing on Google Icon
2/12/2025Alliancebernstein L.P.72,510$1.08M0.0%-94.4%0.079%Search for SEC Filing on Google Icon
2/12/2025Norges Bank34,044$0.51M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/12/2025NEOS Investment Management LLC22,233$0.33M0.0%-39.8%0.024%Search for SEC Filing on Google Icon
2/12/2025WINTON GROUP Ltd72,310$1.08M0.1%+5.4%0.079%Search for SEC Filing on Google Icon
2/11/2025Corebridge Financial Inc.28,935$0.43M0.0%-7.2%0.032%Search for SEC Filing on Google Icon
2/11/2025Vanguard Group Inc.5,389,216$80.25M0.0%-1.5%5.889%Search for SEC Filing on Google Icon
2/11/2025KLP Kapitalforvaltning AS13,900$0.21M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/11/2025AXQ Capital LP10,761$0.16M0.1%N/A0.012%Search for SEC Filing on Google Icon
2/11/2025American Century Companies Inc.97,764$1.46M0.0%+11.1%0.107%Search for SEC Filing on Google Icon
2/11/2025Teacher Retirement System of Texas14,952$0.22M0.0%+19.2%0.016%Search for SEC Filing on Google Icon
2/11/2025Intech Investment Management LLC26,155$0.39M0.0%+63.9%0.029%Search for SEC Filing on Google Icon
2/10/2025Connor Clark & Lunn Investment Management Ltd.64,043$0.95M0.0%N/A0.070%Search for SEC Filing on Google Icon
2/7/2025AlphaQuest LLC7,405$0.11M0.0%-21.5%0.008%Search for SEC Filing on Google Icon
2/7/2025Amundi27,030$0.40M0.0%+137.0%0.030%Search for SEC Filing on Google Icon
2/6/2025Raymond James Financial Inc.35,662$0.53M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/6/2025Victory Capital Management Inc.45,718$0.68M0.0%-5.7%0.050%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.579,623$8.63M0.0%+2.2%0.633%Search for SEC Filing on Google Icon
2/5/2025US Bancorp DE6,887$0.10M0.0%+2,432.0%0.008%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp381,615$5.68M0.0%+8.6%0.417%Search for SEC Filing on Google Icon
2/3/2025Handelsbanken Fonder AB24,800$0.37M0.0%+11.2%0.027%Search for SEC Filing on Google Icon
1/31/2025Principal Financial Group Inc.263,517$3.92M0.0%+3.1%0.288%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers159,264$2.37M0.0%-1.6%0.174%Search for SEC Filing on Google Icon
1/30/2025New York State Teachers Retirement System90,543$1.35M0.0%-3.9%0.099%Search for SEC Filing on Google Icon
1/23/2025R Squared Ltd1,720$26K0.0%N/A0.002%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC28,497$0.42M0.0%-5.2%0.031%Search for SEC Filing on Google Icon
1/6/2025Nordea Investment Management AB218,930$3.25M0.0%+2.5%0.239%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.43,685$0.67M0.0%+2.6%0.048%Search for SEC Filing on Google Icon
12/19/2024Principal Financial Group Inc.255,611$3.91M0.0%-6.8%0.279%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,222,206$18.69M0.0%-0.9%1.336%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC118,693$1.82M0.0%+49.0%0.130%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Arcus Biosciences logo
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's pipeline products include Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial; and AB308, an investigational anti-TIGIT monoclonal antibody, which is in Phase 1b clinical trial to study people with advanced solid and hematologic malignancies. It also develops Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in Phase 2 clinical trial; Quemliclustat, a small-molecule CD73 inhibitor, which is Phase 1b and Phase 2 clinical trial; Zimberelimab, an anti-PD-1 antibody, which is in Phase 2 clinical trial for metastatic cell lung cancer and monotherapy; and AB521, an oral and small-molecule inhibitor of HIF-2a, which is in Phase 1 clinical trial for the treatment of Von Hippel-Lindau disease. In addition, the company's preclinical pipeline products include AB598, a CD39 antibody; and AB801, a small molecule Axl inhibitor. It has a clinical collaboration with AstraZeneca to evaluate domvanalimab in combination with durvalumab in a registrational phase 3 clinical trial in patients with unresectable Stage 3 NSCLC; and BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases. Arcus Biosciences, Inc. was incorporated in 2015 and is headquartered in Hayward, California.
Read More on Arcus Biosciences

Today's Range

Now: $8.30
Low: $8.07
High: $8.34

50 Day Range

MA: $8.84
Low: $6.87
High: $11.09

52 Week Range

Now: $8.30
Low: $6.50
High: $18.98

Volume

503,744 shs

Average Volume

799,201 shs

Market Capitalization

$872.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Who are the company insiders with the largest holdings of Arcus Biosciences?

Arcus Biosciences' top insider shareholders include:
  1. Gilead Sciences, Inc (Major Shareholder)
  2. Terry J Rosen (CEO)
  3. Juan C Jaen (President)
  4. Jennifer Jarrett (COO)
  5. Robert C Goeltz II (CFO)
  6. Yasunori Kaneko (Director)
  7. Alexander Azoy (CAO)
Learn More about top insider investors at Arcus Biosciences.

Who are the major institutional investors of Arcus Biosciences?

Arcus Biosciences' top institutional shareholders include:
  1. Rhumbline Advisers — 0.17%
  2. State of Alaska Department of Revenue — 0.04%
  3. Yousif Capital Management LLC — 0.02%
  4. Allspring Global Investments Holdings LLC — 0.02%
  5. GAMMA Investing LLC — 0.02%
  6. Exchange Traded Concepts LLC — 0.01%
Learn More about top institutional investors of Arcus Biosciences stock.

Which major investors are buying Arcus Biosciences stock?

Within the last quarter, RCUS stock was acquired by institutional investors including:
  1. Rhumbline Advisers
  2. GAMMA Investing LLC
  3. State of Alaska Department of Revenue
  4. Allspring Global Investments Holdings LLC
  5. Exchange Traded Concepts LLC
  6. Yousif Capital Management LLC
Within the last year, these company insiders have bought Arcus Biosciences stock:
  1. Gilead Sciences, Inc (Major Shareholder)
  2. Terry J Rosen (CEO)
  3. Juan C Jaen (President)
Learn More investors buying Arcus Biosciences stock.